Ciancio G et al. |
Current advantage of FK 506 in cadaveric kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623207
|
Pham SM et al. |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience. |
1996 |
Transplant. Proc. |
pmid:8623208
|
Satomura K et al. |
Pharmacokinetics of FK 506 in living-related liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623209
|
Loss M et al. |
Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. |
1996 |
Transplant. Proc. |
pmid:8623210
|
Fryer JP et al. |
Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression. |
1996 |
Arch Surg |
pmid:8546583
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Sher LS et al. |
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623212
|
Millis JM et al. |
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623213
|
Washburn WK et al. |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8623214
|
Kogi M et al. |
Effects of calyculin A and FK506 on the O2- generation of rat peritoneal macrophages. |
1996 |
Tokai J. Exp. Clin. Med. |
pmid:9239803
|
Ketel BL et al. |
Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation. |
1996 |
Transplant. Proc. |
pmid:8623453
|
Kyo M et al. |
Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin. |
1996 |
Transplant. Proc. |
pmid:8623457
|
D'Silva M et al. |
Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623467
|
Pirenne J et al. |
Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623472
|
Ciancio G et al. |
Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. |
1996 |
Transplant. Proc. |
pmid:8623473
|
D'Silva M et al. |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623476
|
Klintmalm GB |
Clinical use of FK 506 in liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623484
|
Butt TR et al. |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506. |
1996 |
Transplant. Proc. |
pmid:8623486
|
Spencer DM et al. |
Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization. |
1996 |
Curr. Biol. |
pmid:8805308
|
Franke EK and Luban J |
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. |
1996 |
Virology |
pmid:8806510
|
Ichikawa Y et al. |
Three-times-daily monotherapy with tacrolimus (FK 506) in kidney transplantation. |
1996 |
Int. J. Urol. |
pmid:8776613
|
Mugiya S et al. |
Renal blood flow and serotonin metabolism in tacrolimus treated rats. |
1996 |
Int. J. Urol. |
pmid:8776615
|
Dmitrewski J et al. |
Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. |
1996 |
J. Hepatol. |
pmid:8778189
|
Schwarz A |
[Drug-induced kidney damage]. |
1996 |
Z Arztl Fortbild (Jena) |
pmid:8779233
|
Newell KA et al. |
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. |
1996 |
Transplantation |
pmid:8779685
|
Lufft V et al. |
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. |
1996 |
Transplantation |
pmid:8779695
|
Walgenbach KJ et al. |
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. |
1996 |
Transplant. Proc. |
pmid:8907896
|
Nüssler NC et al. |
CD8+ host cells infiltrate the intestinal mucosa after allogeneic small bowel transplantation even in the absence of acute rejection. |
1996 |
Transplant. Proc. |
pmid:8907898
|
Wu J et al. |
Reversal of multidrug resistance by tacrolimus hydrate. |
1996 |
Methods Find Exp Clin Pharmacol |
pmid:9121220
|
Perego C et al. |
Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907908
|
Alessiani M et al. |
Combined FK 506 and mycophenolate mofetil immunosuppression prolongs survival after small bowel transplantation in pigs. |
1996 |
Transplant. Proc. |
pmid:8907922
|
Cohen DS et al. |
Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy. |
1996 |
Transplant. Proc. |
pmid:8907923
|
Toyama Y et al. |
Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. |
1996 |
Transplant. Proc. |
pmid:8907924
|
Yamada T et al. |
Synergistic effect of FK 506 and trifluoperazine on the immunosuppression in rat small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907927
|
Rossi G et al. |
Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907932
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Ho S et al. |
The mechanism of action of cyclosporin A and FK506. |
1996 |
Clin. Immunol. Immunopathol. |
pmid:8811062
|
Nishino H et al. |
3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression. |
1996 |
J. Chem. Neuroanat. |
pmid:8811425
|
Sonatore LM et al. |
The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. |
1996 |
Anal. Biochem. |
pmid:8811923
|
Jonas S et al. |
Conversion to tacrolimus after liver transplantation. |
1996 |
Transpl. Int. |
pmid:8748407
|
Cooley HM et al. |
Resolution of pyoderma gangrenosum using tacolimus (FK-506) |
1996 |
Aust N Z J Med |
pmid:8744629
|
Hashino S et al. |
Antitumor effect in cyclosporine A- or FK506-treated mice after syngeneic bone marrow transplantation. |
1996 |
Leuk. Lymphoma |
pmid:8726416
|
Steiner JP et al. |
Immunophilin regulation of neurotransmitter release. |
1996 |
Mol. Med. |
pmid:8784785
|
Herzog D et al. |
Combined bowel-liver transplantation in an infant with microvillous inclusion disease. |
1996 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:8732907
|
Becker G et al. |
Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8962228
|
Kiuchi T et al. |
Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects. |
1996 |
Transplant. Proc. |
pmid:8962229
|
Guckelberger O et al. |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? |
1996 |
Transplant. Proc. |
pmid:8962230
|
Braun F et al. |
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. |
1996 |
Transplant. Proc. |
pmid:8962231
|
Wilczek HE et al. |
Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506). |
1996 |
Transplant. Proc. |
pmid:8962232
|
Yussim A et al. |
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. |
1996 |
Transplant. Proc. |
pmid:8962233
|
Golling M et al. |
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962234
|
Tanabe K et al. |
Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658670
|
Sugito K et al. |
A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658683
|
Degawa H et al. |
Blocking of ICAM-1 and LFA-1 in rat liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8658695
|
Watanabe K et al. |
Immunosuppressive effect of bactobolamine in rat liver allotransplantation. |
1996 |
Transplant. Proc. |
pmid:8658697
|
Tojimbara T et al. |
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. |
1996 |
Transplant. Proc. |
pmid:8658704
|
Yuzawa K et al. |
Topical immunosuppression in skin grafting with FK 506 ointment. |
1996 |
Transplant. Proc. |
pmid:8658707
|
Yagura K et al. |
Pharmacokinetic characteristics of two types of liposomal FK 506. |
1996 |
Transplant. Proc. |
pmid:8658708
|
Ogawa N et al. |
Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation. |
1996 |
Transplant. Proc. |
pmid:8658710
|
Andoh TF et al. |
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. |
1996 |
Kidney Int. |
pmid:8887267
|
Shapiro R et al. |
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. |
1996 |
Transplantation |
pmid:8932264
|
Mysliwiec J et al. |
The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats. |
1996 |
Thromb. Res. |
pmid:8837316
|
Devlin J and Williams R |
Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group. |
1996 |
Transplantation |
pmid:8932266
|
Lamb GD and Stephenson DG |
Effects of FK506 and rapamycin on excitation-contraction coupling in skeletal muscle fibres of the rat. |
1996 |
J. Physiol. (Lond.) |
pmid:8842013
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
Tanaka K et al. |
Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein. |
1996 |
Pharm. Res. |
pmid:8842048
|
Bader A et al. |
Tacrolimus (FK 506) biotransformation in primary rat hepatocytes depends on extracellular matrix geometry. |
1996 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8935714
|
Borvak J et al. |
The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus. |
1996 |
J. Infect. Dis. |
pmid:8843228
|
Galat A |
A large-scale processing of kinetic data files with derivation of the inhibitory constant Ki: an application to proline isomerases. |
1996 |
Comput. Chem. |
pmid:8936426
|
Borg AJ et al. |
15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes. |
1996 |
Transpl. Immunol. |
pmid:8843590
|
Alak AM and Lizak P |
Stability of FK506 in blood samples. |
1996 |
Ther Drug Monit |
pmid:8721287
|
Büttemeyer R et al. |
Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. |
1996 |
Plast. Reconstr. Surg. |
pmid:8532772
|
Yu C et al. |
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation. |
1996 |
Bone Marrow Transplant. |
pmid:8722370
|
Fealy MJ and Press BH |
Pinpointing the moment of allograft rejection. |
1996 |
J Hand Surg Am |
pmid:8724501
|
Hall MN |
The TOR signalling pathway and growth control in yeast. |
1996 |
Biochem. Soc. Trans. |
pmid:8674674
|
Mattila PS |
The actions of cyclosporin A and FK506 on T-lymphocyte activation. |
1996 |
Biochem. Soc. Trans. |
pmid:8674715
|
Adams DH and Liu Q |
FK506 inhibits human lymphocyte migration and the production of lymphocyte chemotactic factors in liver allograft recipients. |
1996 |
Hepatology |
pmid:8675167
|
Bridges ND et al. |
Lung transplantation in infancy and early childhood. |
1996 |
J. Heart Lung Transplant. |
pmid:8889985
|
Iwasaki K et al. |
Binding of tacrolimus (FK506) with human plasma proteins re-evaluation and effect of mycophenolic acid. |
1996 |
Res. Commun. Mol. Pathol. Pharmacol. |
pmid:9029671
|
Bousvaros A et al. |
Tacrolimus (FK-506) treatment of fulminant colitis in a child. |
1996 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:8890089
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|
Timmerman LA et al. |
Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. |
1996 |
Nature |
pmid:8893011
|
Inutsuka K et al. |
Reconstruction of trachea and carina with immediate or cryopreserved allografts in dogs. |
1996 |
Ann. Thorac. Surg. |
pmid:8893587
|
Ezeamuzie CI |
Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506. |
1996 |
Int. J. Immunopharmacol. |
pmid:8894806
|
Ockenfels HM et al. |
The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytes. |
1996 |
Skin Pharmacol. |
pmid:8896120
|
Nash RA et al. |
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. |
1996 |
Blood |
pmid:8896434
|
Rozen TD et al. |
Treatment-refractory cyclosporine-associated headache: relief with conversion to FK-506. |
1996 |
Neurology |
pmid:8909459
|
Kay JE |
Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. |
1996 |
Biochem. J. |
pmid:8670043
|
Schmaldienst S and Horl WH |
Bacterial infections during immunosuppression - immunosuppressive agents interfere not only with immune response, but also with polymorphonuclear cell function. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8672015
|
Hartley AD et al. |
cAMP inhibits bud growth in a yeast strain compromised for Ca2+ influx into the Golgi. |
1996 |
Mol. Gen. Genet. |
pmid:8709962
|
Tokime T et al. |
Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. |
1996 |
Neurosci. Lett. |
pmid:8710192
|
Dan Y et al. |
IL-3 augments TCR-mediated responses of type 2 CD4 T cells. |
1996 |
J. Immunol. |
pmid:8598473
|
Soubrane O and Houssin D |
[Liver transplantation. Current aspects]. |
1996 |
Presse Med |
pmid:8728904
|
Lampen A et al. |
Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber. |
1996 |
Br. J. Pharmacol. |
pmid:8732283
|
Beretta L et al. |
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. |
1996 |
EMBO J. |
pmid:8599949
|
Saada V et al. |
Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506. |
1996 |
Int. J. Immunopharmacol. |
pmid:8732436
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|
Asante-Korang A et al. |
Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects. |
1996 |
J. Heart Lung Transplant. |
pmid:8732602
|
Gruessner RW et al. |
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. |
1996 |
Transplantation |
pmid:8600635
|
Rifai N et al. |
The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. |
1996 |
Clin. Biochem. |
pmid:8601324
|